(al-beer -ee-oh) (β Cyg) A beautiful double star, the second brightest star in the constellation Cygnus. The primary is an orange giant with a deep blue companion 35″ away. mv : 3.1 (A), 5.1 (B); spectral type: K5 II (A), B8 V (B).
28 November 2018 - US-based lower-middle-market private equity firm Huron Capital's building automation and energy services platform, Albireo Energy, has acquired energy management company Taylor Consulting and Contracting, the firm said.
Albireo Pharma announced the first patient has been enrolled in PEDFIC-1, a Phase 3 clinical trial of lead product candidate A4250, an ileal bile acid transporter inhibitor being studied for the treatment of patients with progressive familial intrahepatic cholestasis.
13 October 2010 - Swedish biotechnology company Albireo yesterday reported encouraging top-line results from a Phase IIb study in chronic idiopathic constipation (CIC) assessing efficacy and safety of three different dose levels (5, 10 and 15 mg orally once a day) of the investigational drug A3309 during an eight-week trial.
Albireo Pharma announced that data on a pharmacodynamic marker measured in its completed Phase 2 clinical trial evaluating lead product candidate A4250 in children with cholestatic liver disease and pruritus were presented during a poster session at the European Association for the Study of the Liver The International Liver Congress 2018 in Paris.